{"id":"W2063331655","doi":"10.2147/tcrm.s38852","title":"Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab","year":2013,"lang":"en","type":"review","venue":"Therapeutics and Clinical Risk Management","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Adalimumab; Medicine; Infliximab; Golimumab; Ulcerative colitis; Adverse effect; Biologic Agents; Tumor necrosis factor alpha; Clinical trial; Vedolizumab; Crohn's disease; Disease; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000901836,0.0008921717,0.001467801,0.002349454,0.0003167354,0.0009041585,0.000877042,0.001122567,0.002731572],"category_scores_gemma":[0.0007683995,0.0002994767,0.0006612184,0.002205611,0.0005951838,0.001445418,0.0007729436,0.003203828,0.0018921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006267769,"about_ca_system_score_gemma":0.0008468009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001097485,"about_ca_topic_score_gemma":0.002314806,"domain_scores_codex":[0.9997571,0.00004861936,0.00003835617,0.00004116653,0.00008845723,0.00002631888],"domain_scores_gemma":[0.9996015,0.0001874962,0.00004877385,0.00001055507,0.000107323,0.00004429828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001208359,0.000092189,0.0001286592,0.01156042,0.0000802136,0.0002208409,0.00004817415,0.0002424608,0.001040738,0.002712688,0.02512216,0.9586306],"study_design_scores_gemma":[0.00005343507,0.0001459649,0.0007259068,0.003496719,0.0001050418,0.001470526,0.00004637213,0.00008422477,0.0002934299,0.001331581,0.9922288,0.00001791249],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007021665,0.9988694,0.00008336779,0.0002305813,0.000193018,0.000003391108,0.000006609716,0.000004782278,0.0005386401],"genre_scores_gemma":[0.000459227,0.9984855,0.0001707571,0.000273761,0.0002021702,0.000004556941,0.00001584901,0.000001624205,0.0003865173],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002731572,"threshold_uncertainty_score":0.009137988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06120196587115313,"score_gpt":0.3745149900067927,"score_spread":0.3133130241356396,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}